Navigation Links
'Chemo Brain' After Breast Cancer Backed by Study
Date:9/7/2012

FRIDAY, Sept. 7 (HealthDay News) -- Breast cancer patients treated with chemotherapy are at risk for mild mental deficits known collectively as "chemo brain," a new study finds.

Researchers at the Moffitt Cancer Center in Tampa, Fla., reviewed existing research on brain function ("cognitive" functioning) in breast cancer patients who received standard doses of chemotherapy for at least six months.

The analysis revealed that, on average, these patients had mild impairments in verbal abilities (such as difficulty choosing words) and visual-spatial abilities (such as getting lost more easily).

Mental functioning varied among the patients, with some reporting no problems and others reporting more severe or widespread impairments, the investigators found.

The study was published online Aug. 27 in the Journal of Clinical Oncology.

"Breast cancer patients treated with chemotherapy who have subsequent cognitive deficits should be referred to a neuropsychologist for evaluation and management of the deficits," lead author Heather Jim, whose research focuses on the psychosocial and behavioral aspects of cancer survivorship, said in a Moffitt news release.

"Management usually involves developing an awareness of the situations in which their cognitive difficulties are likely to arise so that they can come up with strategies to compensate," she explained. "Research shows that such strategies can make a big difference in daily life when cognitive difficulties do arise."

More information

The American Cancer Society has more about chemo brain.

-- Robert Preidt

SOURCE: Moffitt Cancer Center, news release, Sept. 4, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
2. Adding bavituximab to second-line chemotherapy doubles response rate
3. Review finds some evidence for chemo brain in breast cancer survivors, Moffitt Cancer Center says
4. More heart problems with 2 chemo drugs for breast cancer
5. Immunodeficient patients with secondary lung disease benefit from combined chemotherapy
6. Chemo During Pregnancy Doesnt Seem to Harm Newborn
7. Mechanisms of acquired chemoresistance in ovarian cancer identified
8. Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy
9. Certain Heart Meds May Give Chemo a Boost
10. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
11. RLIP76 contributes to pancreatic cancer cell resistance to chemotherapy and radiation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Chemo Brain' After Breast Cancer Backed by Study
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017  According to the Centers for ... the end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the ... as mandated by certain health insurance regulations. ... The best time to get a flu shot is by the ...
Breaking Medicine Technology: